{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-036004","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2025-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.705705+00:00","generated_at":"2026-05-23T11:36:14.208303+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CytoSorbents appoints Melanie Grossman as VP & Corp Controller; issues inducement options and RSUs","bullets":["Appointment of Melanie Grossman as VP and Corporate Controller, effective April 14, 2025.","Inducement grant includes 25,000 options at $0.99 exercise price, 10-year term, vesting 50% year 1 then 25% annually.","Also granted 35,000 signing RSUs (change-of-control or 4-year cliff) and 35,000 change-of-control RSUs.","Grossman brings 25 years of experience; previously SVP & Group Controller at Staffing 360 and auditor at Ernst & Young."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-036004","json":"https://secwatch.observer/filing/0001104659-25-036004.json","markdown":"https://secwatch.observer/filing/0001104659-25-036004.md","text":"https://secwatch.observer/filing/0001104659-25-036004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/0001104659-25-036004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/tm2512549d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T11:36:14.208303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}